Blood marker in HELLP syndrome
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study looks at a blood marker called sCD163 in pregnant women with and without HELLP syndrome, a severe pregnancy complication. It aims to see if this marker helps diagnose or track the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be pregnant and between 20 and 42 weeks along.
- If you have HELLP syndrome, you must meet the full criteria: signs of red blood cell breakdown (high LDH or bilirubin), high liver enzymes (AST or ALT), and a low platelet count (below 100,000).
- If you are in the control group, you must have normal blood pressure and no protein in your urine.
- You cannot have autoimmune diseases, chronic kidney or liver disease, or active infections like HIV or hepatitis.
- You cannot have fetal anomalies or have been diagnosed with other pregnancy conditions like gestational diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests (platelet counts and inflammation markers) in women with HELLP syndrome, a serious pregnancy condition. The goal is to see if these blood levels can help predict how the disease will progress, which could lead to better care.
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
This study looks at whether certain blood markers (called angiogenic factors) can help manage high blood pressure in pregnancy without having to deliver the baby early. If you have gestational hypertension, this trial may help doctors decide the best way to keep you and your baby healthy.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
This study is testing a new blood test that might help doctors quickly and safely identify preeclampsia, a serious pregnancy condition. If you're at risk, this test could help you get the right care earlier.
Hear when a new HELLP Syndrome Complicating Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.